<Record>
<Term>Tazasubrate</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Antilipidemic Agent</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Antilipidemic Agent/Tazasubrate</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Tazasubrate</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Adjuvant</BroaderTerm>
<BroaderTerm>Antilipidemic Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>EMD-34853</Synonym>
<Synonym>TAZASUBRATE</Synonym>
<Synonym>Tazasubrate</Synonym>
<Source>NCI Thesaurus</Source>
</Record>
